Stephanie Comrie
Family · Greenville, ILNPI 1003182940
Payments from drug & device makers
Across 328 payments — averaging $16.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- AbbVie$1K
- Lilly USA, LLC$565
- Novo Nordisk$491
- GSK$289
- Boehringer Ingelheim$253
- plus $1K from 21 others
What the payments were for
- Food & beverage$5,259100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 67 | $1,216 |
| AbbVie | 94 | $1,145 |
| Lilly USA, LLC | 30 | $565 |
| Novo Nordisk | 34 | $491 |
| GSK | 17 | $289 |
| Boehringer Ingelheim | 11 | $253 |
| Pfizer | 12 | $212 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $160 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $133 |
| Sanofi-aventis U.S. LLC | 7 | $121 |
| Merck | 5 | $86 |
| Amgen(2 entities) | 4 | $67 |
| Exact Sciences | 4 | $62 |
| Kowa Pharmaceuticals America, Inc. | 4 | $61 |
| Johnson & Johnson | 3 | $54 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $54 |
| Abbott | 3 | $49 |
| Lundbeck LLC | 2 | $39 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Dexcom, Inc. | 2 | $28 |
| Nestle Healthcare Nutrition Inc. | 2 | $23 |
| Lexicon Pharmaceuticals, Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
How this compares
$5,259 in reported general payments places this provider in the 90th percentile of 4,941 family providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 77 | $91,178 |
| JardianceEmpagliflozin | 65 | $84,967 |
| OzempicSemaglutide | 55 | $74,912 |
| RybelsusSemaglutide | 54 | $74,312 |
| FarxigaDapagliflozin Propanediol | 69 | $69,086 |
| Tresiba Flextouch U-200Insulin Degludec | 86 | $67,627 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 57 | $60,508 |
| MounjaroTirzepatide | 45 | $58,942 |
| EliquisApixaban | 61 | $49,554 |
| Nurtec OdtRimegepant Sulfate | 26 | $35,722 |
| JanuviaSitagliptin Phosphate | 22 | $29,617 |
| MyrbetriqMirabegron | 34 | $26,319 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 38 | $24,786 |
| RexultiBrexpiprazole | 11 | $23,042 |
| XareltoRivaroxaban | 28 | $22,396 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $565 | $150,119122 claims |
| Novo NordiskOzempic, Rybelsus | $491 | $149,224109 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,216 | $93,872107 claims |
| PfizerEliquis, Nurtec Odt | $212 | $85,27687 claims |
| Boehringer IngelheimJardiance | $253 | $84,96765 claims |
| GSKTrelegy Ellipta | $289 | $60,50857 claims |
| MerckJanuvia, Belsomra | $86 | $39,39540 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $32 | $23,04211 claims |
| Johnson & JohnsonXarelto | $54 | $22,39628 claims |
| AbbVieSynthroid | $1,145 | $1,97319 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,941 family providers in Illinois.
Other family in Greenville
- Ruth CarricoChicago$582K
- Aleksandra BielawiecBarrington$373K
- Erin SieberNaperville$334K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Brooke KennardBloomington$208K
- Amy BrownellElk Grove Village$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.